How to taper off Lorazepam (Ativan) 0.5mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Tapering Protocol

A gradual taper is essential when discontinuing lorazepam 0.5mg to minimize withdrawal symptoms and ensure patient safety. The recommended approach is to reduce the dose by 25% every 1-2 weeks until complete discontinuation.

Risks of Abrupt Discontinuation

  • Abrupt discontinuation of lorazepam can lead to serious withdrawal reactions including seizures and, rarely, death 1
  • Benzodiazepine withdrawal carries greater risks than opioid withdrawal and should always be conducted gradually 2
  • Withdrawal symptoms may include anxiety, blurred vision, depersonalization, depression, dizziness, fatigue, gastrointestinal issues, headache, hyperacusis, hypertension, irritability, insomnia, memory impairment, muscle pain, panic attacks, photophobia, restlessness, tachycardia, and tremor 1
  • More severe withdrawal symptoms can include catatonia, convulsions, delirium tremens, hallucinations, mania, psychosis, and suicidality 1

Recommended Tapering Schedule for Lorazepam 0.5mg

  • Begin with a 25% reduction of the daily dose every 1-2 weeks 3, 2

  • For lorazepam 0.5mg daily, a sample tapering schedule would be:

    Weeks Daily Dose
    1-2 0.375 mg
    3-4 0.25 mg
    5-6 0.125 mg
    7-8 0 mg
    3, 4
  • If withdrawal symptoms become problematic, slow the taper by extending the time at each dose reduction 3

  • For patients who have been on lorazepam for extended periods, an even slower taper may be necessary, potentially extending over several months 5

Monitoring During Tapering

  • Assess for withdrawal symptoms at each follow-up visit 3
  • Watch for both acute withdrawal symptoms (which occur immediately) and protracted withdrawal syndrome (which can persist for weeks to months) 1
  • Monitor for signs of depression or suicidal ideation, which may emerge or worsen during benzodiazepine discontinuation 1
  • Be alert for rebound anxiety, which may be mistaken for recurrence of the original anxiety disorder 5

Adjunctive Treatments to Support Tapering

  • Consider cognitive-behavioral therapy (CBT) during the taper, which has been shown to increase success rates 2
  • Non-pharmacological interventions such as relaxation techniques and physical activity may help manage anxiety during the taper 3
  • For patients experiencing significant withdrawal symptoms, adjunctive medications may be considered:
    • Buspirone may help manage anxiety symptoms during the taper process 3, 6
    • Avoid starting other CNS depressants during the tapering period 2

Special Considerations

  • If the patient is also taking opioids, prioritize benzodiazepine tapering due to the higher risks associated with benzodiazepine withdrawal 2
  • For patients who have been on lorazepam for many years, tapering to doses lower than the standard minimum therapeutic dose before complete discontinuation may be beneficial 5
  • Patients with a history of seizures or who have previously experienced severe withdrawal symptoms may require a more gradual taper and closer monitoring 1

Common Pitfalls to Avoid

  • Avoid tapering too quickly, which increases the risk of withdrawal symptoms 3, 4
  • Don't mistake withdrawal symptoms for recurrence of the original condition, which could lead to unnecessary resumption of medication 5
  • Recognize that protracted withdrawal syndrome can last for weeks to more than 12 months after discontinuation 1
  • Avoid concurrent use of other CNS depressants during the taper period, which can complicate withdrawal 2

References

Guideline

Benzodiazepine Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tapering Protocol for Alprazolam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Buspirone treatment as an aid to benzodiazepine withdrawal.

Journal of psychopharmacology (Oxford, England), 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.